[
  {
    "ts": null,
    "headline": "BD Stock Up Post Tie-Up to Expand Hazardous Drug Contamination Testing",
    "summary": "BDX teams up with ChemoGLO to expand hazardous drug testing, aiming to boost safety in healthcare environments.",
    "url": "https://finnhub.io/api/news?id=b6b336fd9535b4cd5540e1c0fc319a0c52703c0a8b8ddf092df7d67210355ad9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764953580,
      "headline": "BD Stock Up Post Tie-Up to Expand Hazardous Drug Contamination Testing",
      "id": 137715942,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "SOLV",
      "source": "Yahoo",
      "summary": "BDX teams up with ChemoGLO to expand hazardous drug testing, aiming to boost safety in healthcare environments.",
      "url": "https://finnhub.io/api/news?id=b6b336fd9535b4cd5540e1c0fc319a0c52703c0a8b8ddf092df7d67210355ad9"
    }
  },
  {
    "ts": null,
    "headline": "These Are the 3 Hottest Stocks in the S&P 500 Heading Into the New Year. Should You Invest in Them?",
    "summary": "After tepid performances throughout most of 2025, these stocks are showing some upward momentum.",
    "url": "https://finnhub.io/api/news?id=416573e21912f6743fe5f531fa34a0e217244e69a367526041801eeb35e4509c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764923700,
      "headline": "These Are the 3 Hottest Stocks in the S&P 500 Heading Into the New Year. Should You Invest in Them?",
      "id": 137697125,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "SOLV",
      "source": "Yahoo",
      "summary": "After tepid performances throughout most of 2025, these stocks are showing some upward momentum.",
      "url": "https://finnhub.io/api/news?id=416573e21912f6743fe5f531fa34a0e217244e69a367526041801eeb35e4509c"
    }
  },
  {
    "ts": null,
    "headline": "Is It Too Late to Consider Solventum After Its 29.3% Year To Date Rally?",
    "summary": "Wondering if Solventum is still worth a look after its recent run up, or if most of the upside is already priced in? Let us unpack what the current share price is really implying about the company. After trading flat over the last week, Solventum has still climbed 26.0% in the past month and is up 29.3% year to date, adding to a 21.9% gain over the last 12 months from a recent close of $85.26. Those moves have come as investors continue digesting Solventum's progress as a newly stand alone...",
    "url": "https://finnhub.io/api/news?id=4006557d65b17be2a8dba33652824af2a6cdd84174eab8b5db2ff730961b5369",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764918541,
      "headline": "Is It Too Late to Consider Solventum After Its 29.3% Year To Date Rally?",
      "id": 137697829,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "SOLV",
      "source": "Yahoo",
      "summary": "Wondering if Solventum is still worth a look after its recent run up, or if most of the upside is already priced in? Let us unpack what the current share price is really implying about the company. After trading flat over the last week, Solventum has still climbed 26.0% in the past month and is up 29.3% year to date, adding to a 21.9% gain over the last 12 months from a recent close of $85.26. Those moves have come as investors continue digesting Solventum's progress as a newly stand alone...",
      "url": "https://finnhub.io/api/news?id=4006557d65b17be2a8dba33652824af2a6cdd84174eab8b5db2ff730961b5369"
    }
  }
]